Three more Covid-19 vaccine developers have applied to conduct clinical trials in the Philippines, an official of the Department of Science and Technology revealed on Tuesday.
DOST Undersecretary for Research and Development Rowena Cristina Guevara said that West China Hospital , Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd. have submitted their application to the Food and Drug Administration (FDA).
“Evaluation of the two new applications are now ongoing. West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., while the Eubiologics Co. Ltd. have yet to complete their requirements,” Guevara said in an online media forum.
There are already three Covid-19 vaccine clinical trials that have already been approved in the country.
Guevara said that Janssen and Clover Biopharmaceuticals’ clinical trials are ongoing.
“Sinovac’s clinical trial has not yet started and the FDA is awaiting the submission of their protocol amendment,” Guevara said.
Meanwhile, Guevara said that they expect to receive by the end of this month the protocols and specific list of vaccines from the World Health Organization (WHO).
The list will be used for the WHO solidarity trial for Covid-19 vaccines in the country.
Read full article on BusinessMirror